HLT, Inc. is a technology and clinical-stage medical device company developing novel transcatheter valve technologies designed to meet patient and physician needs. The company is committed to driving heart valve therapy forward with next-generation technology to offer patients the highest performing device and physicians with accurate placement, flexibility to reposition and retrieve, and ease of use to achieve excellent and consistent results. The HLT® Meridian® TAVR Valve System is designed to meet not only today’s needs, but future needs of patients and physicians as the indications and markets expand.